Exercise Treatment With Standard Therapy for Metastatic Breast Cancer

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

June 12, 2019

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2026

Conditions
Hormone Receptor Positive Metastatic Breast Cancer
Interventions
OTHER

Exercise Treatment

Exercise sessions will consist of individualized, walking delivered following a non-linear (i.e.,exercise intensity is continually altered and progressed in conjunction with appropriate rest/recovery sessions across the entire intervention period) dosing schedule up to 7 individual treatment sessions/wk for 6 months. Remote supervised exercise sessions will be implemented and monitored using TeleEx. General physical activity as well as exercise performed outside of the structured treatment sessions will be evaluated via continuous monitoring using MSK approved telemedicine / wireless technology.

Trial Locations (10)

10065

Memorial Sloan Kettering Cancer Center, New York

10467

Montefiore Health Systems (Montefiore Medical Center) (Data Collection Only), The Bronx

10604

Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison

11553

Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale

11725

Memorial Sloan Kettering Cancer Center @ Suffolk (Limited protocol activity), Commack

21287

Johns Hopkins Hospital (Data Collection Only), Baltimore

46202

Indiana University (Data Collection Only), Indianapolis

07920

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge

07748

Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown

07645

Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT03988595 - Exercise Treatment With Standard Therapy for Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter